Fatigue News and Research

RSS

Health officials accused over cover up in deaths from vCJD

A cover up on the part of British health authorities meant a man who had been infected with CJD from contaminated blood during a transfusion was not told until he was dying what was really wrong with him.

11 Dec 2006

Reaction to UNAIDS/WHO report on HIV/AIDS

Health officials on Tuesday reacted to a report from UNAIDS and the World Health Organization showing that the number of people living with HIV/AIDS over the past two years has increased and that the worldwide total now stands at nearly 40 million, the New York Times reports (Altman, New York Times, 11/22).

23 Nov 2006

Waltzing is the way to mend a broken heart!

Italian researchers have found that in patients recovering from heart attacks dancing the waltz was as effective as routine training programs for improving heart health.

13 Nov 2006

Chronic fatigue syndrome begins with childhood trauma and stress

According to the latest research traumatic events in childhood, and stress or emotional instability at any period in life, may be linked to the development of chronic fatigue syndrome (CFS).

8 Nov 2006

Cardiologists say a dramatic change is needed in treating some heart patients

According to researchers at Johns Hopkins University in the U.S. a dramatic change is needed in the way hundreds of thousands of Americans with a form of heart failure should be treated.

8 Nov 2006

Chronic fatigue syndrome a public health epidemic says CDC

The Centers for Disease Control and Prevention (CDC) in the United States says more than a million Americans suffer from Chronic fatigue syndrome (CFS).

6 Nov 2006

Environment the culprit in women's higher risk of MS

Researchers in the UK are suggesting that there is an environmental link to the rising number of women being diagnosed with multiple sclerosis (MS) in Canada.

1 Nov 2006

Sad and lonely at bedtime - stress hormone up at dawn

According to a new study older people who go to bed lonely, sad or overwhelmed wake up the following morning with elevated levels of cortisol, the stress hormone linked to depression, obesity and other health problems.

31 Oct 2006

FDA approves Tyzeka for the treatment of adults with chronic hepatitis B

The Food and Drug Administration (FDA) has approved Tyzeka (telbivudine) for the treatment of adults with chronic hepatitis B (HBV), a serious viral infection that attacks the liver and can cause lifelong infection, scarring of the liver (cirrhosis), and eventually liver cancer, liver failure, and death.

26 Oct 2006

Mobile phone use should be banned in cars altogether

Hands-free mobile phones have failed to make the roads safer according to a University of Sussex psychologist.

23 Oct 2006

Tuberculosis fourfold the risk for Celiac sufferers

Swedish researchers are suggesting that people with celiac disease, also known as gluten intolerance, have an increased risk of developing tuberculosis (TB).

17 Oct 2006

Researchers identifiy how immune system contributes to nerve fiber damage caused by multiple sclerosis

Researchers have identified how the body's own immune system contributes to the nerve fiber damage caused by multiple sclerosis, a finding that can potentially aid earlier diagnosis and improved treatment for this chronic disease.

16 Oct 2006

Schizophrenia drug to be used to treat autism

A drug normally used to treat schizophrenia has been given approval by the U.S. the Food and Drug Administration for use in treating the symptoms of autism in children and adolescents.

9 Oct 2006

FDA approves Zolinza for the treatment of cutaneous T-cell lymphoma

The U.S. Food and Drug Administration (FDA) has approved Zolinza (vorinostat) capsules for the treatment of cutaneous T-cell lymphoma (CTCL), a type of skin cancer, to be used when the disease persists, gets worse, or comes back during or after treatment with other medicines.

8 Oct 2006

FDA approves Risperdal to treat irritability associated with autism

The U.S. Food and Drug Administration (FDA) has approved Risperdal (risperidone) orally disintegrating tablets, an adult antipsychotic drug, for the symptomatic treatment of irritability in autistic children and adolescents.

8 Oct 2006

FDA approves FluLaval

The U.S. Food and Drug Administration (FDA) today approved FluLaval, an influenza vaccine to immunize people 18 years of age and older against the disease caused by strains of influenza virus judged likely to cause seasonal flu in the Northern Hemisphere in 2006-2007.

5 Oct 2006

Nicotinamide may help people with multiple sclerosis

Researchers have found a possible way to protect people with multiple sclerosis (MS) from severe long-term disability: increase nervous-system levels of a vital compound, called nicotinamide adenine dinucleotide (NAD), by giving its chemical precursor - nicotinamide, a form of vitamin B3.

19 Sep 2006